Resistance to Proteasome Inhibitors in Cancer Molecular Mechanisms and Strategies to Overcome Resistance /
The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases,...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Dou, Q. Ping (Επιμελητής έκδοσης) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2014.
|
Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Nitric Oxide and Cancer: Pathogenesis and Therapy
Έκδοση: (2015) -
Resistance to Aromatase Inhibitors in Breast Cancer
Έκδοση: (2015) -
Resistance to Immunotoxins in Cancer Therapy
Έκδοση: (2015) -
Resistance to Photodynamic Therapy in Cancer
Έκδοση: (2015) -
PARP Inhibitors for Cancer Therapy
Έκδοση: (2015)